(RTTNews) - Corbus Pharmaceuticals Holdings, Inc. (CRBP) Tuesday announced FDA clearance for its investigational new drug or IND application of CRB-601, a TGFß blocking monoclonal antibody targeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback